
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Chicago - Fluocinolone acetonide (0.01 percent) in a blend of mineral oils and refined peanut oil is an effective therapy for pediatric atopic dermatitis, even in children with peanut allergy, according to Amy S. Paller, M.D.